Technical Analysis for PFE - Pfizer, Inc.

Grade Last Price % Change Price Change
B 29.97 0.88% 0.26
PFE closed up 0.88 percent on Friday, July 19, 2024, on 89 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
Earnings due: Jul 30
*** please verify all earnings dates ***
23 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up

Date Alert Name Type % Chg
180 Bullish Setup Bullish Swing Setup 0.00%
Upper Bollinger Band Walk Strength 0.00%
Gapped Up Strength 0.00%
Overbought Stochastic Strength 0.00%
Shooting Star Candlestick Bearish 0.88%
Stochastic Sell Signal Bearish 0.88%
Upper Bollinger Band Walk Strength 0.88%
Multiple of Ten Bearish Other 0.88%
Overbought Stochastic Strength 0.88%
Upper Bollinger Band Touch Strength 0.88%

   Recent Intraday Alerts

Alert Time
Rose Above Upper Bollinger Band about 4 hours ago
Gap Up Closed about 8 hours ago
Gap Up Partially Closed about 8 hours ago
Reversed from Up about 8 hours ago
Gapped Up (Partial) about 8 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Pfizer, Inc. Description

Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells medicines for people and animals worldwide. Its Primary Care segment offers human prescription pharmaceutical products primarily prescribed by primary-care physicians for Alzheimer's disease, cardiovascular, erectile dysfunction, genitourinary, major depressive disorder, pain, respiratory, and smoking cessation therapeutic and disease areas. The company's Specialty Care and Oncology segment provides human prescription pharmaceutical products for anti-infectives, endocrine disorders, hemophilia, inflammation, ophthalmology, pulmonary arterial hypertension, specialty neuroscience, and vaccines, as well as oncology and oncology-related illnesses. Its Established Products and Emerging Markets segment offers human prescription pharmaceutical products that have lost patent protection or marketing exclusivity in certain countries and/or regions, as well as that are sold in emerging markets, including Asia, Latin America, the Middle East, Eastern Europe, Africa, Turkey, and Central Europe. The company's Animal Health segment offers products and services to prevent and treat disease in livestock and companion animals, including anti-infectives, vaccines, parasiticides, medicinal feed additives, other pharmaceutical products, and other non-pharmaceutical products. Its Consumer Healthcare segment provides non-prescription products in therapeutic categories, such as dietary supplements, pain management, respiratory, and personal care. The company sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. has a strategic collaboration with CytomX Therapeutics, Inc. to develop and commercialize Multiple Probody drug conjugates in oncology. The company was founded in 1849 and is headquartered in New York, New York.


Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: S&P 500 Biopharmaceutical Disease Pain Medication Clinic Neuroscience Pharmaceutical Products Inflammation Alzheimer's Disease Hypertension Ophthalmology Animal Health Dietary Supplement Pain Management Dysfunction Major Depressive Disorder Depressive Disorder Primary Care Pulmonary Arterial Hypertension Smoking Hemophilia Smoking Cessation Anti Infectives Endocrine Disorders Erectile Dysfunction Livestock Producers Prescription Product Prescription Products Genitourinary

Is PFE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 35.7995
52 Week Low 24.8256
Average Volume 33,285,660
200-Day Moving Average 27.95
50-Day Moving Average 28.41
20-Day Moving Average 28.45
10-Day Moving Average 28.99
Average True Range 0.63
RSI (14) 66.33
ADX 18.96
+DI 35.41
-DI 14.82
Chandelier Exit (Long, 3 ATRs) 28.80
Chandelier Exit (Short, 3 ATRs) 28.84
Upper Bollinger Bands 30.04
Lower Bollinger Band 26.86
Percent B (%b) 0.98
BandWidth 11.15
MACD Line 0.47
MACD Signal Line 0.25
MACD Histogram 0.2161
Fundamentals Value
Market Cap 169.22 Billion
Num Shares 5.65 Billion
EPS 0.37
Price-to-Earnings (P/E) Ratio 81.00
Price-to-Sales 2.70
Price-to-Book 1.61
PEG Ratio 1.17
Dividend 1.64
Dividend Yield 5.47%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 30.64
Resistance 3 (R3) 30.58 30.29 30.53
Resistance 2 (R2) 30.29 30.12 30.32 30.49
Resistance 1 (R1) 30.13 30.01 30.21 30.19 30.46
Pivot Point 29.84 29.84 29.88 29.87 29.84
Support 1 (S1) 29.68 29.67 29.76 29.75 29.48
Support 2 (S2) 29.39 29.56 29.42 29.45
Support 3 (S3) 29.23 29.39 29.41
Support 4 (S4) 29.30